Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sarah B. Goldberg"'
Publikováno v:
Oncology and Therapy, Vol 11, Iss 4, Pp 419-431 (2023)
Abstract This podcast, for healthcare professionals (HCPs), patients, and patient advocates, is a discussion among a panel of two patients (and co-founders of the patient advocacy group EGFR Resisters, https://egfrcancer.org/ ) and two oncologists. T
Externí odkaz:
https://doaj.org/article/52597ed9fc0444bdac9a6f26eeac903f
Autor:
Iris K. van Alderwerelt van Rosenburgh, David M. Lu, Michael J. Grant, Steven E. Stayrook, Manali Phadke, Zenta Walther, Sarah B. Goldberg, Katerina Politi, Mark A. Lemmon, Kumar D. Ashtekar, Yuko Tsutsui
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Although small molecule tyrosine kinase inhibitors are effective in lung cancer driven by mutated EGFR, some receptor variants fail to respond. Here, the authors identify structural features of an important set of EGFR variants with reduced inhibitor
Externí odkaz:
https://doaj.org/article/b04886b84f654ae4b677dfc2b5e44cc2
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Lung cancer is the second most common cancer and the most common cause of cancer-related death in the United States. Brain metastases (BM) are detected in 21% of patients with lung cancer at the time of diagnosis and are the sole metastatic site in 3
Externí odkaz:
https://doaj.org/article/2932e1c6eb5b4c4fbe06c476ac67e389
Autor:
Benjamin Y. Lu, MD, Cigdem Isitan, MD, Amit Mahajan, MD, Veronica Chiang, MD, Anita Huttner, MD, Jackson Robinson Mitzner, BS, Sarah F. Wesley, MD, Sarah B. Goldberg, MD, MPH
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 6, Pp 100183- (2021)
Background: Immune checkpoint inhibitors (ICIs) have become an increasingly important tool in cancer treatment, revealing durable responses in several different types of tumors, including NSCLCs. Nevertheless, ICIs carry a risk of immune-mediated tox
Externí odkaz:
https://doaj.org/article/1cb5be012c0047d1ac43a769190a697b
Autor:
Thuy T. Tran, Amit Mahajan, Veronica L. Chiang, Sarah B. Goldberg, Don X. Nguyen, Lucia B. Jilaveanu, Harriet M. Kluger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Abstract Background Little is known about tumor-associated vasogenic edema in brain metastasis, yet it causes significant morbidity and mortality. Our purpose was to characterize edema in patients treated with anti-PD-1 and to study potential causes
Externí odkaz:
https://doaj.org/article/816c288f506d4f4b8d1c72714f74b413
Autor:
Ranee Mehra, Ina Rhee, Naiyer Rizvi, Robert L Ferris, Hussein Tawbi, Matthew D Hellmann, Sarah B Goldberg, Ryan J Sullivan, Helen X Chen, Jong Chul Park, Foluso O Ademuyiwa, Z Alexander Cao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Although immunotherapy can offer profound clinical benefit for patients with a variety of difficult-to-treat cancers, many tumors either do not respond to upfront treatment with immune checkpoint inhibitors (ICIs) or progressive/recurrent disease occ
Externí odkaz:
https://doaj.org/article/fd73b0fbb8884f60901ba9db5264d2cd
Autor:
Raffit Hassan, Patrick M Forde, Edward B Garon, Steven M Dubinett, Roy S Herbst, Charu Aggarwal, Matthew D Hellmann, Sarah B Goldberg, David L Rimm, Sarah Sagorsky, Boris Sepesi, Ramaswamy Govindan, Andrea Ferris, Scott J Antonia, Fred R Hirsch, Lawrence H Schwartz, Marianne Davies, Melissa L Johnson, Shakun Malik, Daniel Morgensztern, Joel W Neal, Jyoti D Patel
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Immunotherapy has transformed lung cancer care in recent years. In addition to providing durable responses and prolonged survival outcomes for a subset of patients with heavily pretreated non-small cell lung cancer (NSCLC), immune checkpoint inhibito
Externí odkaz:
https://doaj.org/article/a7041ff7bb174ceaaf1394ae132d1c32
Autor:
Sarah B Goldberg, Kurt A Schalper, Harriet M Kluger, Lucia B Jilaveanu, Adebowale J Adeniran, Benjamin Y Lu, Adam Aguirre-Ducler, Nicole Gianino, Hailey Wyatt, Matthew Ribeiro, Veronica L Chiang, Joseph N Contessa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/c944367d1c9b437186ea68e2217f1c32